미국의 수술용 가운 레벨 AAMI 3 시장 : 시장 규모, 점유율, 동향 분석 - 사용성별, 가운 유형별, 수술별, 최종 용도별, 지역별, 부문 예측(2025-2033년)

Market Size & Trends:

The U.S. surgical gowns level AAMI 3 market size was estimated at USD 0.19 billion in 2024 and is projected to reach USD 0.49 billion by 2033, growing at a CAGR of 11.31% from 2025 to 2033. The market is primarily driven by growing awareness of infection prevention, enhanced safety and infection control regulations, increasing minimally invasive surgical procedures, and technological advancements in gown materials.

The U.S. surgical gowns Level AAMI 3 market is driven primarily by the increasing demand for infection prevention in healthcare settings, the rising number of arthroscopic orthopedic, endoscopic urological, and mastectomy procedures in the U.S. For instance, according to the Knee Pain Centers of America article published in February 2025, about 700,000 knee arthroscopies are performed yearly, resulting in costs exceeding USD 3.0 billion annually. Further, according to the University of Florida Health, kidney stone disease impacts roughly 1 in every 500 people in the U.S. annually. Throughout their lifetime, about 1 in 8 men-most commonly between ages 40 and 60, and one in sixteen women-most commonly between ages 20 and 50-will experience this condition. In addition, according to Brigham and Women's Hospital, each year, more than 100,000 women undergo some form of mastectomy. Therefore, the increase in kidney stone diseases, breast cancer cases, and the corresponding rise in mastectomy procedures are driving market growth.

AAMI Level 3 surgical gowns offer moderate barrier protection, making them suitable for procedures with moderate fluid exposure, which is common in hospitals and surgical centers. The rising number of surgeries, particularly outpatient procedures, contributes to the growing need for reliable protective apparel. The increasing adoption of minimally invasive procedures, such as laparoscopic surgeries, further propels market growth. For instance, according to an article by North Kansas City Hospital & Meritas Health, approximately 15 million laparoscopic procedures are performed annually in the U.S., making it one of the most frequently conducted surgeries and offering benefits for numerous medical conditions.

Additionally, the growing aging U.S. population contributes to a higher incidence of chronic diseases requiring surgical intervention. Hospitals and surgical centers increasingly seek cost-effective, high-performance gowns, spurring demand for reusable and eco-friendly options. Market consolidation and strategic partnerships among manufacturers and distributors help streamline supply chains and improve availability. Lastly, federal and state funding for hospital preparedness and infection control programs supports sustained investment in high-quality surgical gowns like those meeting AAMI Level 3 standards. In the U.S., founded in 2002, the Administration for Strategic Preparedness & Response, ASPR's Hospital Preparedness Program (HPP), aims to ready the healthcare delivery system to address community needs, ensure equitable access to care, and save lives during disasters and emergencies. By Section 319C-2 of the Public Health Service (PHS) Act, the Administration for Strategic Preparedness and Response (ASPR) allocates Hospital Preparedness Program (HPP) cooperative agreement funding to recipients based on a legislatively mandated formula. Furthermore, the CDC's Public Health Emergency Preparedness (PHEP) Cooperative Agreement funds 50 states, four cities, and 8 U.S. territories and freely associated states.

Regulatory emphasis on healthcare worker and patient safety has led to stricter compliance requirements, boosting the adoption of certified gowns. For instance, according to Cardinal Health, protective apparel, including surgical gowns, is regulated by standards and testing protocols that all manufacturers must meet. These standards are established by the Association for the Advancement of Medical Instrumentation (AAMI). Specifically, ANSI/AAMI PB70:2012 defines a classification system (Levels 1 through 4) for protective apparel used in healthcare settings, including surgical gowns. This classification is based on liquid barrier performance assessed through standardized testing methods. The U.S. Food and Drug Administration (FDA) has adopted ANSI/AAMI PB70:2012 as the mandatory standard that all surgical gown manufacturers must follow.

Technological advancements in fabric materials such as SMS (Spunbond-Meltblown-Spunbond) and multilayer laminates enhance protection and comfort, increasing market competitiveness.

In addition, the growing prevalence of cancer is also expected to boost demand during the forecast period. For instance, according to the American Cancer Society report, in the U.S. in 2025, approximately 316,950 new cases of invasive breast cancer are expected to be diagnosed in women, along with about 2,800 cases in men. Additionally, an estimated 59,080 cases of ductal carcinoma in situ (DCIS) will be diagnosed in women. The year is projected to see around 42,680 breast cancer-related deaths, with 42,170 occurring in women and 510 in men.

U.S. Surgical Gowns Level AAMI 3 Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the U.S. surgical gowns level AAMI 3 market report on the basis of usability gown type, surgery, and end use:

• Usability Outlook (Revenue, USD Million, 2021 - 2033)
• Disposable Gowns
• Reusable Gowns
• Gown Type Outlook (Revenue, USD Million, 2021 - 2033)
• Fabric Reinforced
• Non-fabric Reinforced
• Surgery Outlook (Revenue, USD Million, 2021 - 2033)
• General Surgery
• Orthopedic Surgery
• Endoscopic Surgery
• Gynecological Surgery
• Mastectomy
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Operating Room
• Intensive Care Unit (ICU)
• Emergency Room
• Others

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
• 1.4. Information or Data Analysis
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Surgical Gowns Level AAMI 3 Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
  • 3.2.3. Market opportunity analysis
  • 3.2.4. Market challenge analysis
• 3.3. U.S. Surgical Gowns Level AAMI 3 Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. U.S. Surgical Gowns Level AAMI 3 Market: Usability Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Surgical Gowns Level AAMI 3 Market Movement Analysis
• 4.3. U.S. Surgical Gowns Level AAMI 3 Market Size & Trend Analysis, by Usability, 2021 to 2033 (USD Million)
• 4.4. Disposable Gowns
  • 4.4.1. Disposable Gowns market estimates and forecast 2021 to 2033 (USD Million)
• 4.5. Reusable Gowns
  • 4.5.1. Reusable Gowns market estimates and forecast 2021 to 2033 (USD Million)

Chapter 5. Surgical Gowns Level AAMI 3 Market: Gown Type Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Surgical Gowns Level AAMI 3 Market Movement Analysis
• 5.3. U.S. Surgical Gowns Level AAMI 3 Market Size & Trend Analysis, by Gown Type, 2021 to 2033 (USD Million)
• 5.4. Fabric Reinforced
  • 5.4.1. Fabric reinforced market estimates and forecast 2021 to 2033 (USD Million)
• 5.5. Non-fabric Reinforced
  • 5.5.1. Non-fabric reinforced market estimates and forecast 2021 to 2033 (USD Million)

Chapter 6. Surgical Gowns Level AAMI 3 Market: Surgery Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. U.S. Surgical Gowns Level AAMI 3 Market Movement Analysis
• 6.3. U.S. Surgical Gowns Level AAMI 3 Market Size & Trend Analysis, by Surgical Procedure, 2021 to 2033 (USD Million)
• 6.4. General Surgery
  • 6.4.1. General surgery market estimates and forecast 2021 to 2033 (USD Million)
• 6.5. Orthopedic Surgery
  • 6.5.1. Orthopedic surgery market estimates and forecast 2021 to 2033 (USD Million)
• 6.6. Endoscopic Surgery
  • 6.6.1. Endoscopic surgery market estimates and forecast 2021 to 2033 (USD Million)
• 6.7. Gynecological Surgery
  • 6.7.1. Gynecological surgery market estimates and forecast 2021 to 2033 (USD Million)
• 6.8. Mastectomy
  • 6.8.1. Mastectomy market estimates and forecast 2021 to 2033 (USD Million)
• 6.9. Others
  • 6.9.1. Other market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Surgical Gowns Level AAMI 3 Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. U.S. Surgical Gowns Level AAMI 3 Market Movement Analysis
• 7.3. U.S. Surgical Gowns Level AAMI 3 Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 7.4. Operating Room
  • 7.4.1. Operating room market estimates and forecast 2021 to 2033 (USD Million)
• 7.5. Intensive Care Unit (ICU)
  • 7.5.1. Intensive Care Unit (ICU) market estimates and forecast 2021 to 2033 (USD Million)
• 7.6. Emergency Room
  • 7.6.1. Emergency Room market estimates and forecast 2021 to 2033 (USD Million)
• 7.7. Others
  • 7.7.1. Other market estimates and forecast 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
  • 8.2.1. Cardinal Health.
    • 8.2.1.1. Company overview
    • 8.2.1.2. Financial performance
    • 8.2.1.3. Product benchmarking
    • 8.2.1.4. Strategic initiatives
  • 8.2.2. Owens & Minor
    • 8.2.2.1. Company overview
    • 8.2.2.2. Financial performance
    • 8.2.2.3. Product benchmarking
    • 8.2.2.4. Strategic initiatives
  • 8.2.3. Medline Industries, LP
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Product benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. Henry Schein, Inc.
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Product benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. Boston Scientific Corporation
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Product benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. Standard Textile Co., Inc.
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Product benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. Encompass Group, LLC
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Product benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. Dynarex Corporation
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Product benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. LDI Solutions, LLC
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Product benchmarking
    • 8.2.9.4. Strategic initiatives
    • 8.2.9.5. Strategic initiatives
  • 8.2.10. Taromed
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Product benchmarking
    • 8.2.10.4. Strategic initiatives
• 8.3. Company Market Share Analysis, 2024
• 8.4. List of Other Key Market Players